(lp0
S"NewLink Genetics Corp. NLNK  Wall Street Journal - Nov 5, 2011 P/E Ratio : The Price to Earnings  ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period ..."
p1
aS"Why NewLink Genetics Shares Are Crashing 33% Today Motley Fool - May 10, 2016 What: After NewLink Genetics Corporation  reported that its pancreatic cancer treatment algenpantucel-L failed to outperform standard of care, its shares lost a third of their value at 12:00 p.m.NewLink Genetics Announces Results from Phase 3 IMPRESS Trial of Algenpantucel ... - GlobeNewswire NewLink's Pancreatic Cancer Candidate Fails To Impress - Seeking Alpha"
p2
aS'NewLink Genetics Corporation  Breaks into New 52-Week High on March 13 ... Equities.com - Mar 13, 2017 Shares of NewLink Genetics Corporation  broke into a new 52-week high yesterday, hitting a peak of $22.11. Shares closed at $21.95 after opening at $21.46 for a move of 2.57%.Stock Returns: NewLink Genetics Corporation  is Beating Myriad ... - CML NewsBroker Outlook For The Week Ahead NewLink Genetics Corporation  - Fiscal Standard'
p3
aS"Why NewLink Genetics Corporation Shares Crashed Motley Fool - May 12, 2015 What: Shares in NewLink Genetics Corporation  collapsed by more than 25% earlier today after the company reported disappointing trial news for its pancreatic cancer drug, algenpantucel-L.NewLink Genetics' IMPRESS Phase 3 Pancreatic Cancer Trial with Algenpantucel-L ... - GlobeNewswire NewLink Genetics'  Phase 3 IMPRESS Trial to Continue - StreetInsider.com"
p4
aS'NewLink Genetics Has Many Near-Term Catalysts Seeking Alpha - Sep 27, 2016 NewLink Genetics  is a small biopharmaceutical company  developing novel immuno-oncology product candidates.'
p5
aS'NewLink Genetics Provides Operational &amp; Clinical Update, Reports Fourth ... GlobeNewswire  - Feb 28, 2017 AMES, Iowa, Feb. 28, 2017  -- NewLink Genetics Corporation , a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today reported consolidated financial results&nbsp;...NewLink Genetics Corporation  Moves Higher on Volume Spike for February 28 - Equities.comNewLink Genetics Corporation  Files An 8-K Results of Operations ... - Market Exclusive'
p6
aS'NewLink Genetics: A Classic Value Catalyst Buy Seeking Alpha - Dec 29, 2016 Current information hints that IDO inhibitors have an important role to play in oncology and NewLink Genetics should be given more credit for its pipeline.'
p7
aS'NewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th GlobeNewswire  - Feb 13, 2017 AMES, Iowa, Feb. 13, 2017  -- NewLink Genetics Corporation , a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today announced that it will participate in the&nbsp;...'
p8
aS'NewLink Genetics Corporation  Has a Big Day StockNewsUnion - Mar 3, 2017 NewLink Genetics Corporation  gained 17.5% today on over five times the average daily volume. NewLink Genetics announced that it will be presenting at the 2017 American Association of Cancer Research annual meeting.NewLink Genetics Corporation  Moves Higher on Volume Spike for March 03 - Equities.comNewLink Genetics Corp  Price Target Raised to $15.00 at Jefferies Group LLC - Chaffey Breeze'
p9
aS'NewLink Genetics Corporation  Moves Higher on Volume Spike for February 08 Equities.com - Feb 8, 2017 NewLink Genetics Corporation  traded on unusually high volume on Feb. 08, as the stock gained 2.49% to close at $14.01.NewLink Genetics Corporation  to Post FY2019 Earnings of  Per ... - Community Financial News'
p10
a.